Filing Flows › SeaStar Medical Holding (ICU) › Q2 2025
SeaStar Medical Holding (ICU) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 13, 2025
SeaStar Medical Holding (ICU) reported revenue of $338K for the second quarter 2025 (Q2 2025) and +15% from the quarter before. Operating margin was -519.5%, net loss $2.0M (592.3% of revenue).
SeaStar Medical Holding, Q2 2025: revenue $338K, operating margin -519.5%, net loss $2.0M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $338K | +15% | — |
| Operating profit | −$1.8M | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$3.0M | — | — |
What changed
Revenue was $338K in Q2 2025, up 15% from the previous quarter.
Gross margin was 92.0%. Operating costs exceeded revenue by $1.8M, an operating margin of -519.5%. The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $3.8M loss.
Operating cash flow was −$3.0M. Non-cash charges added back $97K of share-based compensation. Working capital and other items used $1.1M.
Questions
What was SeaStar Medical Holding's revenue in the second quarter 2025?
SeaStar Medical Holding (ICU) reported revenue of $338K for the second quarter 2025 (Q2 2025) and +15% from the quarter before.
Was SeaStar Medical Holding profitable in the second quarter 2025?
Operating loss was $1.8M (-519.5% of revenue) and net loss $2.0M.